References
- Akasbi M, Berenguer J, Saiz A, Brito-Zerón P, Pérez-De-Lis M, Bové A, Diaz-Lagares C, Retamozo S, Blanco Y, Perez-Alvarez R, et al. 2012. White matter abnormalities in primary Sjögren syndrome. QJM. 105:433–443.
- Alexander EL, Beall SS, Gordon B, Selnes OA, Yannakakis GD, Patronas N, Provost TT, McFarland HF. 1988. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med. 108:815–823.
- Alexander GE, Provost TT, Stevens MB, Alexander EL. 1981. Sjögren syndrome: central nervous system manifestations. Neurology. 31:1391–1396.
- Coates T, Slavotinek JP, Rischmueller M, Schultz D, Anderson C, Dellamelva M, Sage MR, Gordon TP. 1999. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. J Rheumatol. 26:1301–1305.
- Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY. 2004. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 83:280–291.
- Dziadkowiak E, Sebastian A, Wiland P, Waliszewska-Prosół M, Wieczorek M, Zagrajek M, Ejma M. 2015. Endogenous event-related potentials in patients with primary Sjögren's syndrome without central nervous system involvement. Scand J Rheumatol. 44:487–494.
- Elbert T, Rockstroh B. 1987. Threshold regulation – a key to the understanding of the combined dynamics of EEG and event-related potentials. J Psychophysiol. 4:317–333.
- Fauchais AL, Magy L, Vidal E. 2012. Central and peripheral neurological complications of primary Sjögren’s syndrome. Presse Med. 4:e485–e493.
- Halgren E, Marinkovic K, Chauvel P. 1998. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol. 106:156–164.
- Kaplan M, Ike R. 2002. The liver is a common non-exocrine target in primary Sjögren's syndrome: a retrospective review. BMC Gastroenterol. 2:21.
- Kawashima N, Shindo R, Kohno M. 1993. Primary Sjögren's syndrome with subcortical dementia. Intern Med. 32:561–564.
- Pokryszko-Dragan A, Zagrajek M, Slotwinski K, Gruszka E, Bilinska M, Podemski R. 2009. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis-a pilot study. Clin Neurol Neurosurg. 111:503–506.
- Polich J, Ilan A, Poceta JS, Mitler MM, Darko DF. 2000. Neuroelectric assessment of HIV: EEG, ERP, and viral load. Int J Psychophysiol. 38:97–108.
- Polich J. 2007. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol. 118:2128–2148.
- Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I. 2013. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Mod Rheumatol. 23:841–845.
- Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. 2014. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: acritical review. J Autoimmun. 51:44–50.
- Tachibana H, Toda K, Sugita M. 1992. Event-related potentials in patients with multiple lacunar infarcts. Gerontology. 38:322–329.
- Teixeira F, Moreira I, Silva AM, Vasconcelos C, Farinha F, E S. 2013. Neurological involvement in primary Sjögren syndrome. Acta Reumatol Port. 38:29–36.
- Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE. 2002. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis. 61:554–558.
- Zoukhri D, Kublin CL. 2001. Impaired neurotransmitter release from lacrimal and salivary nerves of a murine model of Sjögren’s syndrome. Invest Ophthalmol Vis Sci. 42:925–932.